Abstract LB152: ACR-368 synergizes with PD-L1 blockade by coordinated activation of adaptive and innate immunity pathways to achieve robust anti-tumor efficacy
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Amira Elbakry, Taronish Dubash, Joelle Baddour-Sousounis, Jessica Hopkins, Subodh Kumar, Ahmed Youssef, Yingchun Spring Liu, Kate Rappard, Calvin Yang, Ignacio Arribas Diez, Marc Isaksson, Luka Romero, Zachary Best, Nina Lipjankic, Sofija Skoric, Courtney Cooper, Emma Ahrman, Valentina Siino, Portia Lombardo, Corey Xu, Magnus E. Jakobsson, Helen Nilsson, Lei Shi, Ayesha Murshid, Michail Shipitsin, Joon Jung, David Proia, Kristina Masson, Peter Blume-Jensen
Institution: Medicon Village
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154716207
Cites:
Cited by:
Related to: